Cargando…

Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets

The recent emergence of the novel coronavirus (SARS-CoV-2) has raised global concern as it is declared a pandemic by the WHO. However, to date, there is no current regimen to mitigate the molecular pathogenesis of SARS-CoV-2 virus. Curcuminoids, bioactive ingredients present in Curcuma longa (turmer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shanmugarajan, Dhivya, P., Prabitha, Kumar, B. R. Prashantha, Suresh, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056388/ https://www.ncbi.nlm.nih.gov/pubmed/35520671 http://dx.doi.org/10.1039/d0ra03167d

Ejemplares similares

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
por: Dhameliya, Tejas M., et al.
Publicado: (2022)

Studies on Curcumin and Curcuminoids. XXXIX. Photophysical Properties of Bisdemethoxycurcumin
por: Nardo, Luca, et al.
Publicado: (2010)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
por: Karaosmanoglu, Sena, et al.
Publicado: (2022)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2
por: Ghorbani, Mahdi, et al.
Publicado: (2021)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Revisiting Curcumin Chemistry Part I: A New Strategy for the Synthesis of Curcuminoids
por: Rao, E. Venkata, et al.
Publicado: (2011)

Mitochondrial-Targeted Curcuminoids: A Strategy to Enhance Bioavailability and Anticancer Efficacy of Curcumin
por: Reddy, Cheruku Apoorva, et al.
Publicado: (2014)

Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor
por: Durmaz, Bengül, et al.
Publicado: (2020)

Structure/Function Analysis of Truncated Amino-Terminal ACE2 Peptide Analogs That Bind to SARS-CoV-2 Spike Glycoprotein
por: Mackin, Robert T., et al.
Publicado: (2022)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals
por: Praharaj, Manas Ranjan, et al.
Publicado: (2022)

Retro-Curcuminoids as Mimics of Dehydrozingerone and Curcumin: Synthesis, NMR, X-ray, and Cytotoxic Activity
por: Obregón-Mendoza, Marco A., et al.
Publicado: (2016)

High Yield Synthesis of Curcumin and Symmetric Curcuminoids: A “Click” and “Unclick” Chemistry Approach
por: Obregón-Mendoza, Marco A., et al.
Publicado: (2022)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
por: Shen, Min, et al.
Publicado: (2020)

Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020)

Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2
por: Priya, Prerna, et al.
Publicado: (2021)

Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2
por: Golcuk, Mert, et al.
Publicado: (2022)

Novel derivatives of eugenol as potent anti-inflammatory agents via PPARγ agonism: rational design, synthesis, analysis, PPARγ protein binding assay and computational studies
por: Anjum, Noor Fathima, et al.
Publicado: (2022)

Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
por: Song, Wenfei, et al.
Publicado: (2018)

Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective
por: Duru, Chidi Edbert, et al.
Publicado: (2021)

Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
por: Yu, Ran, et al.
Publicado: (2022)

Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection
por: Wang, Jingfang, et al.
Publicado: (2020)

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM
por: Xu, Cong, et al.
Publicado: (2021)

Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021)

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody
por: Omotuyi, Olaposi, et al.
Publicado: (2022)

Curcumin, A Polyphenolic Curcuminoid With Its Protective Effects and Molecular Mechanisms in Diabetes and Diabetic Cardiomyopathy
por: Zheng, Jia, et al.
Publicado: (2018)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

Evaluation of flavonoids as potential inhibitors of the SARS-CoV-2 main protease and spike RBD: Molecular docking, ADMET evaluation and molecular dynamics simulations
por: Hadni, Hanine, et al.
Publicado: (2022)

Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach
por: Hakami, Abdulrahim R.
Publicado: (2022)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Reversed-phase High-performance Liquid Chromatography Method for Analysis of Curcuminoids and Curcuminoid-loaded Liposome Formulation
por: Jangle, R. D., et al.
Publicado: (2013)

Heme binding to the SARS-CoV-2 spike glycoprotein
por: Freeman, Samuel L., et al.
Publicado: (2023)

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19
por: BR, Bharath, et al.
Publicado: (2020)

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
por: Papageorgiou, Anastassios C., et al.
Publicado: (2020)

Novel Derivatives of Eugenol as a New Class of PPARγ Agonists in Treating Inflammation: Design, Synthesis, SAR Analysis and In Vitro Anti-Inflammatory Activity
por: Anjum, Noor Fathima, et al.
Publicado: (2023)

Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study
por: Moharana, Maheswata, et al.
Publicado: (2022)

Pierce into Structural Changes of Interactions Between Mutated Spike Glycoproteins and ACE2 to Evaluate Its Potential Biological and Therapeutic Consequences
por: Hashemi, Zahra Sadat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tk4nbsd77qaiaivi3esgshm7t